TUESDAY, July 2, 2024 (HealthDay News) — A new drug to treat Alzheimer’s disease was approved by the U.S. Food and Drug Administration on Tuesday. In clinical trials, donanemab (Kisunla) modestly slowed the pace of thinking declines among patients in the early stages of the memory-robbing disease. But it alsoContinue Reading
TUESDAY, July 2, 2024 (HealthDay News) — U.S. health officials announced Tuesday that the federal government will pay Moderna $176 million to speed development of a pandemic flu vaccine based on mRNA technology. Such a vaccine could be used to treat bird flu in people, as concern grows about H5N1 casesContinue Reading
TUESDAY, July 2, 2024 (HealthDay News) — Benzodiazepines do not appear to increase dementia risk, but could have subtle long-term effects on brain structure, a new study reports. Researchers found no link between use of the sedative drug and a higher risk of dementia in a group of more thanContinue Reading
TUESDAY, July 2, 2024 (HealthDay News) — Most people addicted to opioids and their loved ones are unaware that their primary care doctor can prescribe a medication to treat the disorder, a new nationwide survey reveals. “We’ve made great strides in making it easier for primary care doctors to prescribeContinue Reading
MONDAY, July 1, 2024 (HealthDay News) — A study based on online Google searches suggests surging U.S. interest in microdosing psychedelics, such as psilocybin, as rules around the use of such drugs begin to relax. But the safety of these drugs isn’t entirely clear, said study lead author Dr. KevinContinue Reading
FRIDAY, June 28, 2024 (HealthDay News) — As a summer wave of COVID infections rolls across the country, U.S. health officials have recommended that all Americans over the age of 6 months get one of the updated COVID vaccines when they become available this fall. The recommendation was issued ThursdayContinue Reading
THURSDAY, June 27, 2024 (HealthDay News) — In new vaccination guidance issued Wednesday, U.S. health officials now recommend that all Americans aged 75 and older get an RSV vaccine before fall arrives. However, those a bit younger — ages 60 to 74 — should only seek the shot if theyContinue Reading
THURSDAY, June 27, 2024 (HealthDay News) — As psilocybin mushrooms become the most popular psychedelic in the United States, some states have started to ease regulations on its recreational use. Now, a new report warns that the federal government will have to decide whether to follow suit. RAND, a nonprofitContinue Reading
TUESDAY, June 25, 2024 (HealthDay News) — A new slow-release pill form of ketamine can quell hard-to-treat depression without producing psychedelic side effects normally associated with the drug, early research suggests. Patients on the strongest dose of ketamine tablets saw significant improvement in their depression compared to a placebo, researchersContinue Reading
TUESDAY, June 25, 2024 (HealthDay News) — As scorching summer temperatures drive Americans indoors and millions travel for vacations and family gatherings, COVID infections are again climbing, U.S. health officials warned Monday. In evidence that suggests a COVID summer wave is underway, case counts are most likely increasing in 39 states andContinue Reading